Drug Shortage Report for ARSENIC TRIOXIDE FOR INJECTION
Report ID | 235163 |
Drug Identification Number | 02492768 |
Brand name | ARSENIC TRIOXIDE FOR INJECTION |
Common or Proper name | ARSENIC TRIOXIDE FOR INJECTION |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | ARSENIC TRIOXIDE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | PACK OF 10 VIALS |
ATC code | L01XX |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2024-08-31 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-10-01 |
Company comments | The resupply date is TBD. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-10-01 | French | Compare |
v4 | 2024-10-01 | English | Compare |
v3 | 2024-09-01 | English | Compare |
v2 | 2024-08-13 | French | Compare |
v1 | 2024-08-13 | English | Compare |
Showing 1 to 5 of 5